Treatment response of wart lesions to sensitization by Candida antigen in comparison with cryotherapy

Phase 2

• Conditions: common wart; wart.

• Registration Number: IRCT2015012016955N5
• Lead Sponsor: Vice chancellor for research of Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

patients older than 15 years that have verucca vulgaris and plantar warts whom referred to dermatology clinic of Quaem hospital;
no prior allergic response to mumps or Candida antisera; not be pregnant or lactating; no primary or iatrogenic immuno-supression; no infection with human immunodeficiency virus type 1( HIV1); no hypersensitivity to lidocaine; no previous treatment for wart during 1 month ago
Exclusion criteria:Taking any treatment for wart during study

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
esion improvement rate. Timepoint: Weekly for cryotherapy until 10 weeks, every 3 weeks for Candida antigen until three doses. Method of measurement: Measuring the size of two largest perpendicular diameter of lesion in millimeter.

Secondary Outcome Measures

Name	Time	Method
Side effects. Timepoint: Weekly for cryotherapy group and each 3 weeks for candida antigen group. Method of measurement: Clinical evaluation.